Bavarian Nordic A/S : Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
April 17, 2021 at 06:00 am EDT
Share
COPENHAGEN, Denmark, April 17, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Gerard van Odijk
2.
Reason for the notification
a)
Position/status
Chairman of the Board of Bavarian Nordic A/S
b)
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Bavarian Nordic A/S
b)
LEI
2138006JCDVYIN6INP51
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Shares
DK0015998017
b)
Nature of the transaction
Acquisition of shares (vesting of restricted stock units)
c)
Price(s) and volume(s)
Price(s)
Volume(s)
DKK 138.43
2,709
d)
Aggregated information
Aggregated volume
Price
2,709 DKK 375,000.00
e)
Date of the transaction
2021-04-17
f)
Place of the transaction
Outside a trading venue
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Anders Gersel Pedersen
2.
Reason for the notification
a)
Position/status
Deputy Chairman of the Board of Bavarian Nordic A/S
b)
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Bavarian Nordic A/S
b)
LEI
2138006JCDVYIN6INP51
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Shares
DK0015998017
b)
Nature of the transaction
Acquisition of shares (vesting of restricted stock units)
c)
Price(s) and volume(s)
Price(s)
Volume(s)
DKK 138.46
1,625
d)
Aggregated information
Aggregated volume
Price
1,625 DKK 225,000.00
e)
Date of the transaction
2021-04-17
f)
Place of the transaction
Outside a trading venue
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Erik G. Hansen
2.
Reason for the notification
a)
Position/status
Member of the Board of Bavarian Nordic A/S
b)
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Bavarian Nordic A/S
b)
LEI
2138006JCDVYIN6INP51
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Shares
DK0015998017
b)
Nature of the transaction
Acquisition of shares (vesting of restricted stock units)
c)
Price(s) and volume(s)
Price(s)
Volume(s)
DKK 138.50
1,083
d)
Aggregated information
Aggregated volume
Price
1,083 DKK 150,000.00
e)
Date of the transaction
2021-04-17
f)
Place of the transaction
Outside a trading venue
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Frank Verwiel
2.
Reason for the notification
a)
Position/status
Member of the Board of Bavarian Nordic A/S
b)
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Bavarian Nordic A/S
b)
LEI
2138006JCDVYIN6INP51
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Shares
DK0015998017
b)
Nature of the transaction
Acquisition of shares (vesting of restricted stock units)
c)
Price(s) and volume(s)
Price(s)
Volume(s)
DKK 138.50
1,083
d)
Aggregated information
Aggregated volume
Price
1,083 DKK 150,000.00
e)
Date of the transaction
2021-04-17
f)
Place of the transaction
Outside a trading venue
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Elizabeth McKee Anderson
2.
Reason for the notification
a)
Position/status
Member of the Board of Bavarian Nordic A/S
b)
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Bavarian Nordic A/S
b)
LEI
2138006JCDVYIN6INP51
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Shares
DK0015998017
b)
Nature of the transaction
Acquisition of shares (vesting of restricted stock units)
c)
Price(s) and volume(s)
Price(s)
Volume(s)
DKK 138.50
1,083
d)
Aggregated information
Aggregated volume
Price
1,083 DKK 150,000.00
e)
Date of the transaction
2021-04-17
f)
Place of the transaction
Outside a trading venue
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Peter Kürstein
2.
Reason for the notification
a)
Position/status
Member of the Board of Bavarian Nordic A/S
b)
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Bavarian Nordic A/S
b)
LEI
2138006JCDVYIN6INP51
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Shares
DK0015998017
b)
Nature of the transaction
Acquisition of shares (vesting of restricted stock units)
c)
Price(s) and volume(s)
Price(s)
Volume(s)
DKK 138.50
1,083
d)
Aggregated information
Aggregated volume
Price
1,083 DKK 150,000.00
e)
Date of the transaction
2021-04-17
f)
Place of the transaction
Outside a trading venue
About Bavarian Nordic Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacture and commercialization of life-saving vaccines. We are a global leader in smallpox vaccines and have been a long-term supplier to the U.S. Strategic National Stockpile of a non-replicating smallpox vaccine, which has been approved by the FDA under the trade name JYNNEOS®, also for the protection against monkeypox. The vaccine is approved as a smallpox vaccine in Europe under the trade name IMVANEX® and in Canada under the trade name IMVAMUNE®. Our commercial product portfolio furthermore contains the market-leading vaccine Rabipur®/RabAvert® against rabies and Encepur® against tick-borne encephalitis. Using our live virus vaccine platform technology, MVA-BN®, we have created a diverse portfolio of proprietary and partnered product candidates designed to save and improve lives by unlocking the power of the immune system, including an Ebola vaccine, MVABEA®, which is licensed to the Janssen Pharmaceutical Companies of Johnson & Johnson. We are also committed to the development of a next generation COVID-19 vaccine based on an in-licensed capsid virus-like particle technology. The vaccine candidate, ABNCoV2, is currently being investigated in clinical trials. For more information visit www.bavarian-nordic.com.
Contacts Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43 US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600
Bavarian Nordic A/S specializes in the development, manufacturing and commercialization of cancer immunotherapies and vaccines for the prevention and treatment of infectious diseases.
Net sales by revenue source are divided between sales of products (97.8%) and services (2.2%).
Net sales are distributed geographically as follows: the United States (36.5%), Canada (22%), France (10.5%), Germany (10.1%), Spain (6.1%), Australia (4.8%), Switzerland ( 1.5%), Sweden (1%), Chile (0.9%), Taiwan (0.8%), the United Kingdom (0.6%), Hong Kong (0.2%), Saudi Arabia (0.1%), and others (4.9%).
Bavarian Nordic A/S : Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such